The introduction of miR-203 to miR-203-deficient CML cell lines resulted in a decrease in BCR-ABL1 expression and subsequent decrease in CML cell proliferation (Bueno et al., 2008). The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.